Xialian Xu

2.3k citations
61 papers · 1.7k indexed · h-index 23
Topics
Acute Kidney Injury Research (17 papers)MicroRNA in disease regulation (13 papers)Chronic Kidney Disease and Diabetes (8 papers)

In The Last Decade

Xialian Xu

57 papers receiving 1.7k citations

Peers

Xialian Xu
Comparison fields: 5 of 109
  • Molecular Biology 927
  • Cancer Research 610
  • Nephrology 410
  • Surgery 210
  • Pathology and Forensic Medicine 144
Replace Alison J. Kriegel with:
Alison J. Kriegel United States
Kelley S. Brodsky United States
Amrutesh S. Puranik United States
Xiao‐Bo Liao China
Katsuhiko Asanuma Japan
Eirini Kefaloyianni United States
Olivia Lenoir France
Liping Yu United States
Ahmed Saad United States
Hongtao Sun Canada
Xialian Xu relative to Alison J. Kriegel United States Alison J. Kriegel's profile →
Citations per field
00.5×1.5×2.1×
Alison J. Kriegel · 1×
Citations per year

Countries citing papers authored by Xialian Xu

Since Specialization
Citations

This map shows the geographic impact of Xialian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xialian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xialian Xu more than expected).

Fields of papers citing papers by Xialian Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xialian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xialian Xu. The network helps show where Xialian Xu may publish in the future.

Co-authorship network of co-authors of Xialian Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xialian Xu. A scholar is included among the top collaborators of Xialian Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xialian Xu. Xialian Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 0
4 1
5 4
6 5
7 1
8 2
9 1
10 7
11 12
12 12
13 2
14 25
15 25
16 35
17 33
18 42
19 146
20 87

About Xialian Xu

Xialian Xu is a scholar working on Nephrology, Cancer Research and Critical Care and Intensive Care Medicine, having authored 61 papers that have together received 1.7k indexed citations. Recurring topics across this work include Acute Kidney Injury Research (17 papers), MicroRNA in disease regulation (13 papers) and Chronic Kidney Disease and Diabetes (8 papers). The work is most often cited by research in Nephrology (410 citations), Cancer Research (610 citations) and Molecular Biology (927 citations). Xialian Xu has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Yi Fang, Mingyu Liang, Jiachang Hu, Xiaoqiang Ding, Alison J. Kriegel, Zhijie Chang, Xiaoqiang Ding, Fen‐Biao Gao, Xiaofang Yu and Nana Song. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026